 Home > Medical News > Latest Medical News > China Biopharmaceuticals' self-developed class 1 new drug P2X3 receptor antagonist received clinical approval for the first time

China Biopharmaceuticals' self-developed class 1 new drug P2X3 receptor antagonist received clinical approval for the first time

 Last Update: 2021-12-26
 Source: Internet
 Author: User

Tags

ind clinical trial

atp adenosine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Text: Sunshine

On December 16, the official website of CDE showed that the clinical trial application of TCR1672, a subsidiary of China Biopharmaceuticals, was approved for the treatment of refractory chronic cough

The P2X3 receptor is a ligand-gated ion channel in the purinergic receptor family

TCR1672 is a second-generation highly selective P2X3 receptor antagonist independently developed by Tide Pharmaceuticals.

Currently, there is no drug with the same target on the market globally

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.